OTL-38
OTL-38 Uses, Dosage, Side Effects, Food Interaction and all others data.
OTL-38 is under investigation in clinical trial NCT02769533 (A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma).
Trade Name | OTL-38 |
Generic | OTL-38 |
Type | |
Formula | C61H67N9O17S4 |
Weight | Average: 1326.49 Monoisotopic: 1325.353776429 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here OTL-38